Therapeutic Monitoring and Variability of Atazanavir in HIV-Infected Patients, With and Without HCV Coinfection, Receiving Boosted or Unboosted Regimens-Reference-Cited by-同舟云学术

Therapeutic Monitoring and Variability of Atazanavir in HIV-Infected Patients, With and Without HCV Coinfection, Receiving Boosted or Unboosted Regimens

Published:2011-06 Issue:3 Volume:33 Page:303-308
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Regazzi Mario,Villani Paola,Gulminetti Roberto,Cusato Maria,Brandolini Michela,Tinelli Carmine,Barassi Alessandra,Maserati Renato,Sighinolfi Laura,Monforte Antonella D'Arminio,Melzi D'Eril Gian Vico

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. Therapeutic drug monitoring. An aid to optimising response to antiretroviral drugs?;Aarnoutse;Drugs,2003

2. Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic.;Ray;Br J Clin Pharmacol,2005

3. Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice.;Cleijsen;J Antimicrob Chemother,2007

4. Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoring.;Rodriguez-Novoa;AIDS Res Human Retrov,2008

5. British HIV Association guidelines on the treatment of HIV-1-infected adults with antiretroviral therapy 2008.;Gazzard;HIV Med,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semi-quantification and Potency Verification of the HIV Protease Inhibitor Based on the Matrix-Capsid Protein Immobilized Nickel (II)/NTA-Tol/Graphene Oxide/SPCE Electrochemical Biosensor;ACS Omega;2023-05-12

2. Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assay;Analytica Chimica Acta;2019-09

3. No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients;PLOS ONE;2018-09-20

4. Fosamprenavir/ritonavir in patients with viral hepatitis coinfection: an observational multicohort study;HIV Clinical Trials;2016-03-16

5. Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort;PLOS ONE;2016-02-05